Advertisement
Screener

Siga Technologies INC (SIGA) Cost of Revenue

1.6 / 5 stars · 32/98 Roast Me

Siga Technologies INC Cost of Revenue

Siga Technologies INC (SIGA) reported Cost of Revenue of $17.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement

us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06

  • Siga Technologies INC cost of goods and services sold for the quarter ending 2026-06-30 was $17.56M, a 31.28% decline year-over-year.
  • Siga Technologies INC cost of goods and services sold for the quarter ending 2026-03-31 was $2.94M, a 1764.41% increase year-over-year.
  • Siga Technologies INC cost of goods and services sold for the quarter ending 2025-12-31 was $2.99M, a 78.84% decline year-over-year.
  • Siga Technologies INC cost of goods and services sold for the quarter ending 2025-09-30 was $1.00M, a 38.16% decline year-over-year.
  • Siga Technologies INC cost of goods and services sold for fiscal 2025 was $29.70M, a 5.07% decline from fiscal 2024.
  • Siga Technologies INC cost of goods and services sold for fiscal 2024 was $31.29M, a 75.53% increase from fiscal 2023.
  • Siga Technologies INC cost of goods and services sold for fiscal 2023 was $17.83M, a 70.86% increase from fiscal 2022.
  • Siga Technologies INC cost of goods and services sold for fiscal 2022 was $10.43M, a 37.16% decline from fiscal 2021.
Period endCost of Goods and Services Sold 3 monthCost of Goods and Services Sold 6 monthCost of Goods and Services Sold 9 monthCost of Goods and Services Sold 12 month
2026-06-30$17.56M
10-Q · filed 2026-08-06
$20.50M
10-Q · filed 2026-08-06
$23.49M
derived: sum of 3 quarters · filed 2026-08-06
$24.49M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$2.94M
10-Q · filed 2026-05-07
$5.93M
derived: sum of 2 quarters · filed 2026-05-07
$6.93M
derived: sum of 3 quarters · filed 2026-05-07
$32.49M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$2.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$3.99M
derived: sum of 2 quarters · filed 2026-03-10
$29.55M
derived: sum of 3 quarters · filed 2026-08-06
$29.70M
10-K · filed 2026-03-10
2025-09-30$1.00M
10-Q · filed 2025-11-06
$26.56M
derived: sum of 2 quarters · filed 2026-08-06
$26.71M
10-Q · filed 2025-11-06
$40.85M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$25.55M
10-Q · filed 2026-08-06
$25.71M
10-Q · filed 2026-08-06
$39.84M
derived: sum of 3 quarters · filed 2026-08-06
$41.46M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$157.74K
10-Q · filed 2026-05-07
$14.29M
derived: sum of 2 quarters · filed 2026-05-07
$15.91M
derived: sum of 3 quarters · filed 2026-05-07
$28.22M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$14.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$15.75M
derived: sum of 2 quarters · filed 2026-03-10
$28.06M
derived: sum of 3 quarters · filed 2026-03-10
$31.29M
10-K · filed 2026-03-10
2024-09-30$1.62M
10-Q · filed 2025-11-06
$13.93M
derived: sum of 2 quarters · filed 2025-11-06
$17.16M
10-Q · filed 2025-11-06
$31.96M
derived: sum of 4 quarters · filed 2026-03-10
2024-06-30$12.31M
10-Q · filed 2025-08-05
$15.54M
10-Q · filed 2025-08-05
$30.34M
derived: sum of 3 quarters · filed 2026-03-10
$31.24M
derived: sum of 4 quarters · filed 2026-03-10
2024-03-31$3.23M
10-Q · filed 2025-05-08
$18.03M
derived: sum of 2 quarters · filed 2026-03-10
$18.93M
derived: sum of 3 quarters · filed 2026-03-10
$19.90M
derived: sum of 4 quarters · filed 2026-03-10
2023-12-31$14.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$15.70M
derived: sum of 2 quarters · filed 2026-03-10
$16.67M
derived: sum of 3 quarters · filed 2026-03-10
$17.83M
10-K · filed 2026-03-10
2023-09-30$896.54K
10-Q · filed 2024-11-07
$1.87M
derived: sum of 2 quarters · filed 2024-11-07
$3.02M
10-Q · filed 2024-11-07
$3.90M
derived: sum of 4 quarters · filed 2025-03-11
2023-06-30$974.42K
10-Q · filed 2024-08-01
$2.12M
10-Q · filed 2024-08-01
$3.01M
derived: sum of 3 quarters · filed 2025-03-11
$6.95M
derived: sum of 4 quarters · filed 2025-03-11
2023-03-31$1.15M
10-Q · filed 2024-05-07
$2.03M
derived: sum of 2 quarters · filed 2025-03-11
$5.98M
derived: sum of 3 quarters · filed 2025-03-11
$6.86M
derived: sum of 4 quarters · filed 2025-03-11
2022-12-31$881.38K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$4.83M
derived: sum of 2 quarters · filed 2025-03-11
$5.71M
derived: sum of 3 quarters · filed 2025-03-11
$10.43M
10-K · filed 2025-03-11
2022-09-30$3.95M
10-Q · filed 2023-11-07
$4.83M
derived: sum of 2 quarters · filed 2023-11-07
$9.55M
10-Q · filed 2023-11-07
$24.82M
derived: sum of 4 quarters · filed 2024-03-12
2022-06-30$882.10K
10-Q · filed 2023-08-08
$5.60M
10-Q · filed 2023-08-08
$20.87M
derived: sum of 3 quarters · filed 2024-03-12
$20.96M
derived: sum of 4 quarters · filed 2024-03-12
2022-03-31$4.72M
10-Q · filed 2023-05-04
$19.99M
derived: sum of 2 quarters · filed 2024-03-12
$20.08M
derived: sum of 3 quarters · filed 2024-03-12
$21.07M
derived: sum of 4 quarters · filed 2024-03-12
2021-12-31$15.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
$15.36M
derived: sum of 2 quarters · filed 2024-03-12
$16.35M
derived: sum of 3 quarters · filed 2024-03-12
$16.60M
10-K · filed 2024-03-12
2021-09-30$83.28K
10-Q · filed 2022-11-03
$1.08M
derived: sum of 2 quarters · filed 2022-11-03
$1.33M
10-Q · filed 2022-11-03
$5.66M
derived: sum of 4 quarters · filed 2023-03-02
2021-06-30$995.99K
10-Q · filed 2022-08-04
$1.25M
10-Q · filed 2022-08-04
$5.58M
derived: sum of 3 quarters · filed 2023-03-02
$11.14M
derived: sum of 4 quarters · filed 2023-03-02
2021-03-31$250.85K
10-Q · filed 2022-05-05
$4.58M
derived: sum of 2 quarters · filed 2023-03-02
$10.14M
derived: sum of 3 quarters · filed 2023-03-02
$14.94M
derived: sum of 4 quarters · filed 2023-03-02
2020-12-31$4.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$9.89M
derived: sum of 2 quarters · filed 2023-03-02
$14.69M
derived: sum of 3 quarters · filed 2023-03-02
$14.80M
10-K · filed 2023-03-02
2020-09-30$5.56M
10-Q · filed 2021-11-04
$10.36M
derived: sum of 2 quarters · filed 2021-11-04
$10.47M
10-Q · filed 2021-11-04
$10.60M
derived: sum of 4 quarters · filed 2022-03-03
2020-06-30$4.80M
10-Q · filed 2021-08-05
$4.91M
10-Q · filed 2021-08-05
$5.04M
derived: sum of 3 quarters · filed 2022-03-03
$5.77M
derived: sum of 4 quarters · filed 2022-03-03
2020-03-31$109.09K
10-Q · filed 2021-05-06
$239.29K
derived: sum of 2 quarters · filed 2022-03-03
$976.57K
derived: sum of 3 quarters · filed 2022-03-03
$976.57K
derived: sum of 4 quarters · filed 2022-03-03
2019-12-31$130.20K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$867.47K
derived: sum of 2 quarters · filed 2022-03-03
$867.47K
derived: sum of 3 quarters · filed 2022-03-03
$1.78M
10-K · filed 2022-03-03
2019-09-30$737.27K
10-Q · filed 2020-11-05
$737.27K
derived: sum of 2 quarters · filed 2020-11-05
$1.65M
10-Q · filed 2020-11-05
2019-06-30$0.00
10-Q · filed 2020-08-06
$915.37K
10-Q · filed 2020-08-06
2019-03-31$915.37K
10-Q · filed 2020-05-06
2018-12-31$95.27M
10-K · filed 2021-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B